{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:33:48Z","timestamp":1790948028468,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010174","name":"University of Colorado","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010174","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bbmt.2019.06.021","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T12:27:20Z","timestamp":1561638440000},"page":"2091-2097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1094-043X","authenticated-orcid":false,"given":"Taylor","family":"Morrisette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda G.","family":"Van Matre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1238-8199","authenticated-orcid":false,"given":"Scott W.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valida","family":"Bajrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheen Z.","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Benamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8182-4076","authenticated-orcid":false,"given":"Gerard R.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4618-1703","authenticated-orcid":false,"given":"Stephanie","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas N.","family":"Fish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Gutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.06.021_bib0001","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/668023","article-title":"Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report","volume":"33","author":"Kamboj","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0002","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1086\/322616","article-title":"Clostridium difficile infection in patients with neutropenia","volume":"33","author":"Gorschl\u00fcter","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0003","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/phar.1914","article-title":"Evaluation of risk factors for Clostridium difficile infection in hematopoietic stem cell transplant recipients","volume":"37","author":"Scardina","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0004","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0005","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1111\/j.1399-0012.2010.01331.x","article-title":"Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation","volume":"25","author":"Chopra","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0006","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/cid\/cir1035","article-title":"Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients","volume":"54","author":"Alonso","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0007","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.3748\/wjg.v20.i21.6602","article-title":"Hematologic diseases: high risk of Clostridium difficile associated diarrhea","volume":"20","author":"Gweon","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0008","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/cid\/ciw401","article-title":"Efficacy of oral vancomycin in preventing recurrent Clostridium difficile infection in patients treated with systemic antimicrobial agents","volume":"63","author":"Van Hise","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0009","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/ajg.2016.417","article-title":"Efficacy of secondary prophylaxis with vancomycin for preventing recurrent Clostridium difficile infections","volume":"111","author":"Carignan","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1060028017727756","article-title":"Vancomycin prophylaxis for prevention of Clostridium difficile infection recurrence in renal transplant patients","volume":"52","author":"Splinter","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0011","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/cid\/ciy822","article-title":"Oral vancomycin prophylaxis is highly effective in preventing Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients","volume":"68","author":"Ganetsky","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0012","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hemonc.2018.05.001","article-title":"Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant","volume":"11","author":"Prohaska","year":"2018","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0013","unstructured":"Centers for Disease Control and Prevention. Multidrug-resistant organism and Clostridioides difficile infection (MDRO\/CDI) module. Available at: https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/12pscmdro_cdadcurrent.pdf. Accessed January 2019."},{"key":"10.1016\/j.bbmt.2019.06.021_bib0014","unstructured":"U.S. Department of Health and Human Services; National Institutes of Health; National Cancer Institute. Common terminology criteria for adverse events (CTCAE). Version 5.0. November 2017. Available at: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_8.5x11.pdf. Accessed October 15, 2018."},{"key":"10.1016\/j.bbmt.2019.06.021_bib0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1086\/511792","article-title":"Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system","volume":"28","author":"Dubberke","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0016","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/588293","article-title":"Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin","volume":"47","author":"Al-Nassir","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0017","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/jac\/dkt129","article-title":"Community-acquired Clostridium difficile infection and antibiotics: a meta-analysis","volume":"68","author":"Deshpande","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2016.03.008","article-title":"Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis","volume":"48","author":"Vardakas","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0019","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.bbmt.2015.04.016","article-title":"Intestinal blautia is associated with reduced death from graft-versus-host disease","volume":"21","author":"Jenq","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0020","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.20112408","article-title":"Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation","volume":"209","author":"Jenq","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0021","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1128\/AAC.00090-08","article-title":"Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant Enterococci during treatment of Clostridium difficile-associated disease","volume":"52","author":"Al-Nassir","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02237-17","article-title":"Tapering courses of oral vancomycin induce persistent disruption of the microbiota that provide colonization resistance to Clostridium difficile and vancomycin-resistant Enterococci in mice","volume":"62","author":"Tomas","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0023","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0024","first-page":"1","article-title":"Does extending Clostridium difficile treatment in patients who are receiving concomitant antibiotics reduce the rate of relapse?","volume":"15","author":"Kaki","year":"2016","journal-title":"Internet J Infect Dis"},{"issue":"suppl 6","key":"10.1016\/j.bbmt.2019.06.021_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/1469-0691.12046","article-title":"Can we identify patients at high risk of recurrent Clostridium difficile infection?","volume":"18","author":"Kelly","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0026","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.06.021_bib0027","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1473-3099(17)30751-X","article-title":"Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b\/4 trial","volume":"18","author":"Guery","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119304057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119304057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:06:56Z","timestamp":1761059216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119304057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1083879119304057"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.06.021","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}